Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery

Andrew B. Lassman

Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian, New York, NY

Mei-Yin C. Polley

Department of Public Health Sciences, University of Chicago, Chicago, IL

Fabio M. Iwamoto

10Department of Neuro-Oncology, Columbia University Irving Medical Center, New York, NY

Vinai Gondi

Andrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cor...

Erik P. Sulman

Jedd D. Wolchok

Minesh P. Mehta